We recommend using a newer internet browser, such as Google Chrome or Microsoft Edge, to optimize your browsing experience.

Skip to main content

Long Term Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for MS

- Relapsing Remitting Multiple Sclerosis
- Completed

Study Title: A Study to Evaluate the Long Term Safety and Effectiveness of Novantrone Therapy Followed by Copaxone Treatment for Multiple Sclerosis

Teva Identifier: PM025

ClinicalTrials.gov Identifier: NCT00203086

Study Status: Completed

Trial Condition(s): Relapsing Remitting Multiple Sclerosis

Interventions: Drug: Copaxoneֲ®

Study Description: Please refer to ClinicalTrials.gov for a description of the trial

Click for participation criteria and map of study locations

neurology icon for clinical trials

Key Participation Requirements

Gender: Female, Male

Age Range: 20 Years to 57 Years

Trial Duration: 10/01/2005 - 12/01/2009

Study Type

Observational